ARCHIVES

Only 20 Percent Of At-Risk Patients Are Screened For HBV Before Therapy

This article is from The Cancer Letter archive.

Vol. 34 No. 11 | November 25, 2011

Download PDF Visit The Full Archive

Related Articles

FDA Considering Ways To Improve Process Of Secondary Approvals Of Cancer Drugs

November 1, 1991

In Brief: ESMO Names Annual Award Winners

October 10, 2014

Controversial Toxicology Protocol Is “Getting The Information We Need;” Additionally Revision Made

March 2, 1984

NCI Cooperative Group, Cancer Center Trials Listed

September 30, 2005

Facilities Survey: $2.5 Billion Will Be Required From 1986-1990, With NCI’s Share At $678 Million

April 12, 1985

Abbott Offers New Education Awards

June 12, 1987